La Vanguardia, La Razón, Correo Farmacéutico, Health Canal, among other national and international media, have published an article about the research led by Antonio Zorzano, from IRB Barcelona, and Fernando Albericio, from the University of Barcelona. This study reveals activators of mitochondrial protein Mitofusin 2 that may be valuable in the treatment of type 2 diabetes.
Link to La Vanguardia
Link to Correo Farmacéutico
Link to Health Canal
Oriol Gallego, IRB Barcelona Alumni is currently a Group Leader at the Pompeu Fabra University (Barcelona).
Oriol talks about his current research projects, his relationship with IRB Barcelona and about how it is to create his own group.
Ana Janic received her PhD in 2011 after completing her her doctoral studies in Cayetano González’s Cell Division Laboratory.
The jury for the prize acknowledged the outstanding quality of Ana Janic’s contributions to science, and her seniority along her career.
The Institute has signed a 5-year collaboration agreement to promote the exchange of faculty members and scientific collaboration with the Hokkaido University.
